<DOC>
	<DOCNO>NCT00289289</DOCNO>
	<brief_summary>The purpose study find specialized program AT500 EnRhythm pacemaker reduce number irregular heartbeat upper chamber heart reduce symptom ( shortness breath , dizziness , others ) .</brief_summary>
	<brief_title>Reducing Episodes Septal Pacing Efficacy Confirmation Trial ( RESPECT )</brief_title>
	<detailed_description>The purpose study confirm AT500 intervention pace effectiveness data previously see ASPECT clinical trial gather additional data understand effectiveness intervention pace feature . Specifically , goal trial demonstrate reduction frequency symptomatic atrial tachycardia/atrial fibrillation recurrence intervention pace feature patient pace indication history atrial tachyarrhythmias atrial pacing lead locate region Bachmann 's Bundle .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Tachycardia , Supraventricular</mesh_term>
	<criteria>Subjects fast and/or slow heartbeat need dual chamber pacing ( pace atrium ventricle ) determine doctor . Subjects history occasional fast heartbeat originate upper heart chamber . Subjects experience least two symptomatic episode fast heartbeat three month prior enrollment . Subjects expect stay heart medication length study . Subjects permanent ( chronic ) persistent ( selfterminating ) atrial fibrillation ( fast heartbeat originate upper heart chamber ) . Subjects atrial fibrillation due reversible cause , i.e . electrolyte imbalance . Subjects current immediate implantable cardioverter defibrillator ( ICD ) recipient .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Atrial Tachyarrhythmia</keyword>
	<keyword>Arrhythmia</keyword>
	<keyword>Bradycardia</keyword>
	<keyword>Cardiac Pacemaker</keyword>
	<keyword>IPG Indication</keyword>
	<keyword>Pacing</keyword>
</DOC>